Applications for the Odyssey Imaging System
APPLICATIONS for the

ODYSSEY® CLx

Applications for the Odyssey CLx Infrared Imaging System

RNAi ANALYSIS

Poster Presentation

Society for Biomolecular Science 2010

[Read More] or [Download]
 

Webinars

Use of the In-Cell Western™ Assay on RNAi Screens
Gregory Hoffman, PhD, Harvard Medical School

RNAi Knockdown Using Quantitative Western
Blotting and In-Cell Western Assays

Harry Osterman, PhD

Western Blot and RNAi

Quantitative Western blotting is an essential tool for every step in your RNAi studies:

  • Choosing an RNAi vehicle (siRNA or shRNA or other RNA-producing vector construct),

  • Confirming level of knockdown of the target gene,

  • Determining the impact of target gene knockdown on a phenotype such as cell proliferation, cell migration, cell cycle, or cell signaling pathways.

 

The Odyssey CLx Infrared Imaging System provides accurate digital protein data for your RNAi studies.

  • Raw data can be normalized for increased accuracy using one of the two independent channels (colors) to monitor a control protein.

  • Stable fluorescent signal is directly proportional to amount of target for consistent data.

  • Wide linear range allows knockdown levels involving both weak and strong signals to be measured accurately in a single image without the bleed over of signal from adjacent “blow out” bands.

  • In-Cell Western assays also offer additional throughput for more complex studies, as well as exceptionally consistent data (Z’-factor).1 The ICW has recently been demonstrated as a powerful cellular assay for genome-wide RNAi screens. 2

[ABOVE] Figure 1. Validation of siRNA knockdown in A431 cells by two-color quantitative Western Each siRNA target is detected in green. In red, tubulin was detected as used as a loading control to normalize for sample variation. Graph indicates % of target expression in siRNA-treated cells, relative to controls. In each blot, the marker is at the left, the negative control is in the center, and the siRNA is at the right.

 

Figure 2. Clear, detailed blot images of siRNA knockdown of ERK2 was performed in A431 cells. ERK2 detection is shown in green (primary antibody binds both ERK isoforms); tubulin loading control is shown in red. In this Western blot, the spatial resolution of ERK isoforms demonstrates that when ERK2 expression is lowered with siRNA treatment, ERK1 expression increases.


1. Boveia, V et al. Using the Z’-Factor Coefficient to Monitor Quality of Near-Infrared Fluorescent Cell-Based Assays.  LI-COR Biosciences (2009).

2. Hoffmann et al. A functional siRNA screen for novel regulators of mTORC1 signaling. Poster presentation, ASCB Annual Meeting (2008)

In-Cell Western and RNAi

The In-Cell Western™ can be used in a functional siRNA screen measuring the effects of knockdowns in cultured cells. 

Hoffmann et al.1 used In-Cell Western screening to assess the effects of knockdowns on mTORC1-dependent phosphorylation of ribosomal protein S6 (rpS6).

  • HeLa cells were transfected with siRNA and screened for phosphorylation of prS6 at Ser235/236.

  • NHS ester cell labeling was used for cell number normalization.

  • The Dharmacon Human Druggable Genome siRNA library gave 7,317 genes from the human genome that are likely targets for pharmacological inhibition.

  • A pilot small molecule screen was performed with a library of ~2500 compounds.

Results of pilot small molecule screen

[ABOVE] Figure 1. (A) ) Results of pilot small molecule screen performed with a library of ~2500 known bioactive compounds. Compounds with average Z-score < -2 are considered hits and are shown in red. Known inhibitors of mTORC1 signaling found in the library are shown in green. Star-shaped symbols represent compounds with > 4-fold reduction in cell number.

(B) Plate to plate reproducibility is shown for a representative plate from the small molecule library.

  • Knockdown of components required for both the growth factor and amino acid branches of the mTORC1 signaling network caused reduction in phospho-rpS6.

  • Known genes involved in growth factor-mediated inputs leading to rpS6 phosphorylation (IRS2, IGF1R, PI3-kinase, PDK1, and S6K2) scored as hits in the screen, validating the approach.

  • In addition to known pathway components, a number of uncharacterized genes scored as strong hits.

  • In-Cell Western RNAi screening was found to be faster and less expensive than high content microscopy (IF), and gave similar or better statistical reproducibility.

rnai screens figure 2

Figure 2.

Schematic of the workflow for the siRNA screen (adapted from Greg Hoffman, Harvard)


1. Hoffmann et al. A functional siRNA screen for novel regulators of mTORC1 signaling. Poster presentation, ASCB Annual Meeting (2008)

Publishing with LI-COR data?

Poster Presentation

Society for Biomolecular Science 2010

[Read More] or [Download]
 

Webinars

Use of the In-Cell Western™ Assay on RNAi Screens
Gregory Hoffman, PhD, Harvard Medical School

RNAi Knockdown Using Quantitative Western
Blotting and In-Cell Western Assays

Harry Osterman, PhD

PubMed

Odyssey Publications: RNA interference 1/2007-6/2009

 

Visit us on You TubeLike us on Facebook!Follow us on TwitterRed the blogger blog

Biotechnology
4647 Superior St Lincoln, NE 68504
Toll-Free: 800-645-4267
Email: biohelp@licor.com
Environmental
4421 Superior Street Lincoln, NE 68504
Toll-Free: 800-447-3576
Email: envsales@licor.com
© 2011 LI-COR Biosciences